FDA
approval
· 2020-12-28
FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Micro Labs Limited)
Summary
The FDA approved a supplemental application for AMLODIPINE AND OLMESARTAN MEDOXOMIL from Micro Labs Limited, enabling its marketing as a fixed-dose combination …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)